3-Bromo-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-yl)benzene, 95.0%, 25g

Ethyl 2-(((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)amino)-2-oxoacetate (Edoxaban Impurity), 97%, 50mg

(S)-2-Amino-2-(3-fluorophenyl)ethanol hydrochloride, 97.0%, 100mg

(R,R)-(-)-2,3-Dimethoxy-1,4-bis(dimethylamino)butane>90.0%(GC)5g

(7aR)-7a-Methyl-2,3,6,7-tetrahydroindene-1,5-dione, 97%, 250mg

8-METHYL-1,3,8-TRIAZASPIRO[4.5]DECANE-2,4-DIONE, 95.0%, 500mg

5-Methylpyrrolo[2,1-f][1,2,4]triazin-4(1H)-one, 95.0%, 1g

9,9-Bis(2-ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)fluorene, 98%, 1g

5-(2-Chloroethyl)-4-methyl-thiazole hydrochloride, 1g

(S)-4-N-Trityl-2-methyl-piperazine, 98.0%, 5g

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-trityl-D-homocysteine, 95+%, 1g

(5-Bromo-2-cyanophenyl)boronic acid, 95.0%, 5g

L-γ-Azidohomalanine hydrochloride, min. 98%, 100 mg, plastic packaging.